Professor of Medicine, University Nebr College of Medicine
Hematology
Dr. Philip J. Bierman, MD
|
|
Give Review
Philip J. Bierman, MD is an expert in the field of Hematology. He attended University of Nebraska Medical Center. University of Nebraska Medical Center is a top medical university. University of Nebraska Medical Center has a rank of 60 in research and a 4 in primary care He received 3 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "America's Top Doctors for Cancer". Philip Bierman is also a published doctor. He has 46 publication published. The most recent publication is: Mortality Patterns Among Recipients of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma in the Past Three Decades. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Mortality Patterns Among Recipients of Autologous Hematopoietic Stem Cell Transplantation for Lymphoma and Myeloma in the Past Three Decades.
- Utility of prechemotherapy evaluation of left ventricular function for patients with Lymphoma.
- Insights on practice variations in the management of lymphoma and Leukemia.
- Phase I/II Study of Bortezomib-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Indolent Non-Hodgkin Lymphoma, Transformed, or Mantle Cell Lymp...
- Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for hodgkin Lymphoma.
- Does functional imaging distinguish nodular lymphocyte-predominant hodgkin Lymphoma from T-cell/histiocyte-rich large B-cell Lymphoma?
- Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium After Doxorubicin-based Chemotherapy.
- Rash and ear swelling in a patient with febrile neutropenia.
- Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell Lymphoma.
- Novel therapy for therapy-resistant mantle cell Lymphoma: Multipronged approach with targeting of hedgehog signaling.
- Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT).
- Recognizing Unusual Manifestations of Hodgkin Lymphoma.
- Lymph node-induced immune tolerance in Chronic lymphocytic leukaemia: a role for caveolin-1.
- Current and emerging pharmacotherapies for primary CNS Lymphoma.
- The addition of rituximab reduces the incidence of secondary central Nervous system involvement in patients with diffuse large B-cell lymphoma.
- Sarcoidosis mimicking recurrent Lymphoma.
- Transplantation for Lymphoma: Good for the Brain as Well as the Body?
- Cell of origin fails to predict survival in patients with diffuse large B-cell Lymphoma treated with autologous hematopoietic stem cell transplantation.
- Hodgkin Lymphoma.
- Central Nervous system cancers.
- Radiation for diffuse large B-cell Lymphoma: more questions than answers.
- Survival disparities in patients with Lymphoma according to place of residence and treatment provider: a population-based study.
- Looking back (and ahead) at salvage treatment for non-Hodgkin Lymphoma.
- Unrelated donor hematopoietic cell transplantation for non-hodgkin Lymphoma: long-term outcomes.
- Antiemesis. Clinical Practice Guidelines in Oncology.
- Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's Lymphoma.
- Adult Burkitt Lymphoma: advances in diagnosis and treatment.
- Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-Cell-like and non-germinal center B-Cell-like subtypes of diffuse la...
- Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin Lymphoma: effect of histological grade and Follicular International Prognostic In...
- Outcomes after hematopoietic stem-Cell transplantation for hematologic malignancies in patients with or without advance care planning.
- ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic Leukemia.
- Natural history of follicular grade 3 non-Hodgkin's Lymphoma.
- Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic Leukemia patients irrespective of 11q23 deletion.
- Lymphoma 2006: classification and treatment.
- Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell Lymphoma.
- Unrelated donor marrow transplantation for B-cell chronic lymphocytic Leukemia after using myeloablative conditioning: results from the Center for International Blood ...
- A prospective study of gastric emptying and its relationship to the development of nausea, vomiting, and anorexia after autologous stem Cell transplantation.
- Prognostic factors of Chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
- Follicular Lymphoma: expanding therapeutic options.
- Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's Lymphoma.
- Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-Cell transplantation.
- A significant diffuse component predicts for inferior survival in grade 3 follicular Lymphoma, but cytologic subtypes do not predict survival.
- Subcutaneous panniculitis-like T-cell Lymphoma: presentation of 2 cases and observations.
- Autologous transplantation for aggressive non-Hodgkin's Lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.
- The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell Lymphoma.
Schools
University Of MissouriKansas City School Of Medicine
University Nebr Med Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
Education
-
City of Hope National Medical Center -
University of Nebraska Medical Center -
University of Missouri - Kansas City School of Medicine
Drug Facts
| NPI NUMBER | 1952369852 | |
| NPPES Provider LastName | BIERMAN | |
| NPPES Provider FirstName | PHILIP | |
| NPPES Provider ZIPCode | 681988102 | |
| NPPES Provider State | NE | |
| Specialty Description | Hematology | |
| Total Claim Count | 297.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952369852 |
| Last Name Of The Provider | BIERMAN |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
|
Margaret J. Rebensdorf, APRN
 This Doctor is OpenDoctor Recommended.
|
|
|
Patrick Tang |
|
Dr. David A. Silverberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Margaret Block, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth H. Cowan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicole A. Shonka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William D. Haire, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stephen J. Lemon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James R. Newland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Qinglong Hu, MD |
|
|
Dr. Michael B. Petzar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Apar Kishor Ganti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Schlueter, MD |
|
|
Dr. Matthew A. Lunning, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret A. Kessinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lori J. Maness, MD
This Doctor is OpenDoctor Recommended.
|